IRCT2013122315246N2已完成未知
BUVB versus minocycline in vitiligo stabiling in unstable vitiligo
Isfahan Medical University0 个研究点目标入组 42 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 8 years 至 50 years（—）
- 性别
- All
入选标准
- •Inclusion criterion: unstable Vitiligo with 20- 50% body surface area involvement.
- •Exclusion criteria: age = 8 years or =50 years old; pregnancy or intention to become pregnant; breastfeeding; other severe systemic diseases e.g. cardiovascular, renal and hepatic failure; segmental vitiligo; acral vitiligo taking any other vitiligo treatment; history of having taken any medication that could interact with minocycline within the previous 3 months; history of photo-mediated disorders such as systemic lupus erythematous and xeroderma pigmentosa (XP) etc; known hypersensitivity to the study medication.
排除标准
- 未提供
研究者
相似试验
招募中
4 期
Efficacy and safety of bimatoprost in vitiligo: A randomized single-blinded controlled studyStable nonsegmental and segmental vitiligo lesions (for the last 3 months)Vitiligo,nonsegmental,segmentalTCTR20170526002Department of dermatology, Siriraj Hospital25
已完成
3 期
Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus PlaceboVitiligoNCT00807690Oslo University Hospital
终止
不适用
Effect of Combination Non Steroidal Antiinflammatory Drugs and Narrowband UVB Treatment in Non-PhotoadaptersVitiligoNCT05256147Henry Ford Health System3
已完成
不适用
The Effect of UVB Phototherapy With Microneedling and Circled Needing in Vitiligo PatientsBrief Description of Focus of Study InsteadNCT03718962Shin Kong Wu Ho-Su Memorial Hospital9
撤回
4 期
Topical Bimatoprost Solution 0.03%in Stable VitiligoVitiligoRepigmentationNCT01202513Gian Sagar Medical College and Hospital20